论文标题
RECASNET:提高两阶段有丝分裂检测框架的一致性
ReCasNet: Improving consistency within the two-stage mitosis detection framework
论文作者
论文摘要
有丝分裂计数(MC)是用于癌症诊断和分级的重要组织学参数,但是从整体滑动组织病理学图像获得MC的手动过程非常耗时,并且容易出错。因此,已经提出了深度学习模型来促进这一过程。现有方法利用了两阶段的管道:识别潜在有丝分裂细胞位置的检测阶段和用于提炼预测信心的分类阶段。但是,由于检测阶段的预测质量差以及两个阶段之间训练数据分布的不匹配,该管道公式可能会导致分类阶段的不一致。在这项研究中,我们提出了一个完善的级联网络(RECASNET),这是一种增强的深度学习管道,可通过三个改进来减轻上述问题。首先,使用窗口搬迁来减少检测阶段产生的差差差差的差异数量。其次,使用另一个深度学习模型进行对象重新编写,以调整核心较差的对象。第三,在分类阶段引入了改进的数据选择策略,以减少培训数据分布的不匹配。在两个大尺度有丝分裂人物识别数据集,皮肤皮肤肥大细胞肿瘤(CCMCT)和犬乳腺癌(CMC)上评估了Recasnet,这导致有丝分细胞检测的F1得分可提高44.1%的F1分数的44.1%predicate predicationge pethuction predicationgage predicate predicationge(mcape)。基于Recasnet的技术可以推广到其他两阶段对象检测网络,并应有助于改善广泛的数字病理应用中深度学习模型的性能。
Mitotic count (MC) is an important histological parameter for cancer diagnosis and grading, but the manual process for obtaining MC from whole-slide histopathological images is very time-consuming and prone to error. Therefore, deep learning models have been proposed to facilitate this process. Existing approaches utilize a two-stage pipeline: the detection stage for identifying the locations of potential mitotic cells and the classification stage for refining prediction confidences. However, this pipeline formulation can lead to inconsistencies in the classification stage due to the poor prediction quality of the detection stage and the mismatches in training data distributions between the two stages. In this study, we propose a Refine Cascade Network (ReCasNet), an enhanced deep learning pipeline that mitigates the aforementioned problems with three improvements. First, window relocation was used to reduce the number of poor quality false positives generated during the detection stage. Second, object re-cropping was performed with another deep learning model to adjust poorly centered objects. Third, improved data selection strategies were introduced during the classification stage to reduce the mismatches in training data distributions. ReCasNet was evaluated on two large-scale mitotic figure recognition datasets, canine cutaneous mast cell tumor (CCMCT) and canine mammary carcinoma (CMC), which resulted in up to 4.8% percentage point improvements in the F1 scores for mitotic cell detection and 44.1% reductions in mean absolute percentage error (MAPE) for MC prediction. Techniques that underlie ReCasNet can be generalized to other two-stage object detection networks and should contribute to improving the performances of deep learning models in broad digital pathology applications.